These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27465646)

  • 1. Long-term follow-up of HIV seroconverters in microbicide trials - rationale, study design, and challenges in MTN-015.
    Riddler SA; Husnik M; Gorbach PM; Levy L; Parikh U; Livant E; Pather A; Makanani B; Muhlanga F; Kasaro M; Martinson F; Elharrar V; Balkus JE;
    HIV Clin Trials; 2016 Sep; 17(5):204-11. PubMed ID: 27465646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.
    Riddler SA; Husnik M; Ramjee G; Premrajh A; Tutshana BO; Pather A; Siva S; Jeenarain N; Nair G; Selepe P; Kabwigu S; Palanee-Phillips T; Panchia R; Mhlanga F; Levy L; Livant E; Patterson K; Elharrar V; Balkus J
    PLoS One; 2017; 12(6):e0178594. PubMed ID: 28658251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
    Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
    AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).
    Fogel JM; Wang L; Parsons TL; Ou SS; Piwowar-Manning E; Chen Y; Mudhune VO; Hosseinipour MC; Kumwenda J; Hakim JG; Chariyalertsak S; Panchia R; Sanne I; Kumarasamy N; Grinsztejn B; Makhema J; Pilotto J; Santos BR; Mayer KH; McCauley M; Gamble T; Bumpus NN; Hendrix CW; Cohen MS; Eshleman SH
    J Infect Dis; 2013 Nov; 208(10):1624-8. PubMed ID: 23908493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study.
    Wynne J; Muwawu R; Mubiru MC; Kamira B; Kemigisha D; Nakyanzi T; Kabwigu S; Nakabiito C; Kiweewa Matovu F
    HIV Clin Trials; 2018 Oct; 19(5):165-171. PubMed ID: 30370830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials.
    Mhlanga FG; Noguchi L; Balkus JE; Kabwigu S; Scheckter R; Piper J; Watts H; O'Rourke C; Torjesen K; Brown ER; Hillier SL; Beigi R
    HIV Clin Trials; 2018 Feb; 19(1):8-14. PubMed ID: 29268654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of rectal microbicides for HIV prevention.
    McGowan I
    Expert Opin Drug Deliv; 2014 Jan; 11(1):69-82. PubMed ID: 24266648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.
    Gulick RM; Ribaudo HJ; Shikuma CM; Lalama C; Schackman BR; Meyer WA; Acosta EP; Schouten J; Squires KE; Pilcher CD; Murphy RL; Koletar SL; Carlson M; Reichman RC; Bastow B; Klingman KL; Kuritzkes DR;
    JAMA; 2006 Aug; 296(7):769-81. PubMed ID: 16905783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert.
    Kim HN; Tabet SR; Corey L; Celum CL
    Vaccine; 2006 Jan; 24(4):532-9. PubMed ID: 16242816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
    Nachega JB; Hislop M; Dowdy DW; Gallant JE; Chaisson RE; Regensberg L; Maartens G
    AIDS; 2008 Oct; 22(16):2117-25. PubMed ID: 18832875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbicides for prevention of HIV infection: clinical efficacy trials.
    Abdool Karim SS; Baxter C
    Curr Top Microbiol Immunol; 2014; 383():97-115. PubMed ID: 23695725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
    Mulu A; Maier M; Liebert UG
    PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.
    Smurzynski M; Collier AC; Koletar SL; Bosch RJ; Wu K; Bastow B; Benson CA
    HIV Clin Trials; 2008; 9(4):269-82. PubMed ID: 18753121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) cell count, viral load, and drug resistance patterns among heterosexual breakthrough HIV infections in a study of oral preexposure prophylaxis.
    Chirwa LI; Johnson JA; Niska RW; Segolodi TM; Henderson FL; Rose CE; Li JF; Thigpen MC; Matlhaba O; Paxton LA; Brooks JT
    AIDS; 2014 Jan; 28(2):223-6. PubMed ID: 24361682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
    Kesho Bora Study Group
    Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003-2014.
    Huang P; Tan J; Ma W; Zheng H; Lu Y; Wang N; Peng Z; Yu R
    BMJ Open; 2015 May; 5(5):e007508. PubMed ID: 26002691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.